Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GENETRON HOLDINGS LIMITED

(GTH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Genetron, AstraZeneca to Collaborate to Develop Solid Tumor Tests in China

11/30/2021 | 05:04am EST


ę MT Newswires 2021
All news about GENETRON HOLDINGS LIMITED
01/10GENETRON : Health Reiterates Full Year 2021 Revenue Guidance - Form 6-K
PU
01/10Genetron Health Reiterates Full Year 2021 Revenue Guidance
AQ
01/10Genetron Holdings Limited Reiterates Full Year 2021 Revenue Guidance
CI
2021Asian ADRs Decline in Wednesday Trading
MT
2021BTIG Adjusts Genetron Holdings' Price Target to $17 From $21, Reiterates Buy Rating
MT
2021Genetron Health's Social Contribution Campaign to Make Precision Medicine More Accessib..
AQ
2021Genetron Holdings Q3 Non-IFRS Loss Widens; Revenue Rises; Lowers 2021 Revenue Guidance
MT
2021GENETRON : Health Announces Co-Development Agreement with AstraZeneca R&D China for Person..
PU
2021Genetron Holdings Limited Reports Earnings Results for the Third Quarter and Nine Month..
CI
2021GENETRON : 3Q21 Presentation
PU
More news
Analyst Recommendations on GENETRON HOLDINGS LIMITED
More recommendations
Financials (USD)
Sales 2021 83,0 M - -
Net income 2021 -71,2 M - -
Net Debt 2021 - - -
P/E ratio 2021 -13,0x
Yield 2021 -
Capitalization 417 M 417 M -
Capi. / Sales 2021 5,02x
Capi. / Sales 2022 3,69x
Nbr of Employees 799
Free-Float -
Chart GENETRON HOLDINGS LIMITED
Duration : Period :
Genetron Holdings Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENETRON HOLDINGS LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 4,69 $
Average target price 14,51 $
Spread / Average Target 209%
EPS Revisions
Managers and Directors
Si Zhen Wang Chief Executive Officer & Director
Ce Xu Chief Financial Officer
Wei-Wu He Chairman
Hai Yan Chief Scientific Officer & Director
Yu Chen Jiao Chief Technology Officer & Director
Sector and Competitors
1st jan.Capi. (M$)
GENETRON HOLDINGS LIMITED-23.11%417
MODERNA, INC.-19.39%83 008
LONZA GROUP AG-15.15%53 950
IQVIA HOLDINGS INC.-12.33%47 252
SEAGEN INC.-11.33%25 068
ICON PUBLIC LIMITED COMPANY-13.98%21 684